GeneDx Holdings Corp.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $11.0M | $329.4M | $315.0M |
| Jun 2022 | $11.0M | $637.3M | $284.6M |
| Sep 2022 | $10.7M | $561.3M | $191.4M |
| Dec 2022 | $6.3M | $253.7M | $123.9M |
| Mar 2023 | $6.3M | $328.5M | $201.9M |
| Jun 2023 | $6.3M | $296.1M | $156.7M |
| Sep 2023 | $6.1M | $254.3M | $87.4M |
| Dec 2023 | $52.7M | $228.0M | $99.7M |
| Mar 2024 | $52.3M | $207.2M | $83.7M |
| Jun 2024 | $52.2M | $194.0M | $56.1M |
| Sep 2024 | $52.0M | $204.5M | $57.9M |
| Dec 2024 | $51.9M | $245.2M | $85.2M |
| Mar 2025 | $51.8M | $257.4M | $99.7M |
| Jun 2025 | $51.7M | $277.1M | $74.1M |
| Sep 2025 | $51.6M | $292.3M | $96.0M |
| Dec 2025 | $48.2M | $308.2M | $105.0M |
| Mar 2026 | $96.7M | $254.1M | $93.9M |
| Jun 2026 | $96.8M | $244.2M | $60.3M |